Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Second COVID-19 Wave: Collateral Impact on Patients of Liver Disease-A Record Based Cross-Sectional Study.

NCT05167305 is registered in ClinicalTrials.gov with Institute of Liver and Biliary Sciences, India as lead sponsor.

NCT NCT05167305
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05167305 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Second COVID-19 Wave: Collateral Impact on Patients of Liver Disease-A Record Based Cross-Sectional Study.
Lead sponsor
Institute of Liver and Biliary Sciences, India
Phase
Observational
Overall status
Completed
Start date
December 22, 2021
Completion date
December 31, 2021
Enrollment
1,316 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver diseases